# Blood Collection Market > Blood Collection Market Research Report By Type (Vacutainer, Syringes, Blood Collection Tubes, Blood Bags), By Method (Manual Blood Collection, Automated Blood Collection, Capillary Blood Collection), By End Use (Hospitals, Diagnostic Laboratories, Blood Banks, Home Care), By Application (Transfusion, Diagnostic Testing, Research) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.93% - **2024:** $ 5.13 Billion - **2025:** $ 5.44 Billion - **2035:** $ 9.67 Billion - **Key Players:** Thermo Fisher Scientific (US), BD (US), Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Greiner Bio-One (DE), Cardinal Health (US), Sekisui Medical (JP), F. Hoffmann-La Roche (CH) **Report ID:** MRFR/HC/5548-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/blood-collection-market-7013 --- ## Market Summary As per MRFR analysis, the Blood Collection Market Size was estimated at 5.13 USD Billion in 2024. The Blood Collection industry is projected to grow from 5.44 USD Billion in 2025 to 9.67 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.93% during the forecast period 2025 - 2035. ## Market Drivers ### Market Growth Projections The Global Blood Collection Market Industry is poised for substantial growth, with projections indicating a market value of 7.08 USD Billion in 2024 and an anticipated increase to 10.2 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 3.37% from 2025 to 2035. Various factors contribute to this upward trend, including technological advancements, increasing demand for blood products, and supportive government initiatives. As the market evolves, it is essential to monitor these growth projections closely, as they provide valuable insights into the future landscape of blood collection. ### Rising Demand for Blood Products The Global Blood Collection Market Industry experiences a notable increase in demand for blood products, driven by a growing prevalence of chronic diseases and surgical procedures. As healthcare systems worldwide prioritize blood safety and availability, the market is projected to reach 7.08 USD Billion in 2024. This surge is attributed to the expanding patient population requiring transfusions and the rising awareness of blood donation's importance. Furthermore, advancements in blood collection technologies enhance efficiency and safety, thereby encouraging more individuals to donate blood. The increasing need for blood products is likely to propel the market further, indicating a robust growth trajectory. ### Government Initiatives and Support Government initiatives play a pivotal role in shaping the Global Blood Collection Market Industry. Various countries implement policies aimed at promoting voluntary blood donation and ensuring the availability of safe blood products. For example, national blood donation campaigns and funding for blood collection infrastructure enhance public awareness and participation. These initiatives are essential in addressing the increasing demand for blood products, particularly in regions with limited access to healthcare. As governments continue to invest in blood collection programs, the market is likely to benefit from improved collection rates and enhanced safety standards, contributing to its overall growth. ### Increasing Awareness of Blood Donation The Global Blood Collection Market Industry is significantly influenced by the rising awareness of blood donation's importance. Educational campaigns and community outreach programs aim to inform the public about the critical need for blood donations, especially during emergencies and natural disasters. This heightened awareness is likely to lead to increased donor participation, thereby boosting the availability of blood products. As more individuals recognize the impact of their contributions, the market is expected to grow, aligning with the projected increase in demand for blood products. The collective efforts to promote blood donation are essential for sustaining the market's growth trajectory. ### Technological Advancements in Blood Collection Innovations in blood collection technologies significantly influence the Global Blood Collection Market Industry. The introduction of automated blood collection systems and advanced [blood bags](https://www.marketresearchfuture.com/reports/blood-bag-market-42227) enhances the efficiency and safety of the collection process. For instance, the adoption of closed blood collection systems minimizes contamination risks, which is crucial for maintaining blood quality. As these technologies evolve, they not only streamline operations but also improve donor experience, potentially leading to increased donation rates. The market's growth is further supported by the anticipated CAGR of 3.37% from 2025 to 2035, reflecting the ongoing commitment to enhancing blood collection methodologies. ### Emerging Markets and Healthcare Infrastructure Development Emerging markets present substantial opportunities for the Global Blood Collection Market Industry, particularly as healthcare infrastructure continues to develop. Countries in Asia and Africa are witnessing improvements in their healthcare systems, leading to increased access to blood collection services. As these regions enhance their medical facilities and blood banks, the demand for blood collection products is likely to rise. This growth is further supported by the anticipated market expansion, with projections indicating a market value of 10.2 USD Billion by 2035. The ongoing development of healthcare infrastructure in emerging markets is crucial for meeting the rising demand for blood products. ## Future Outlook The Blood Collection Market is projected to grow at a 5.93% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for blood products, and rising healthcare expenditures. **New opportunities:** - Development of automated blood collection systems for hospitals - Expansion of mobile blood collection units in rural areas - Integration of AI for predictive analytics in blood donation management By 2035, the Blood Collection Market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Application: Blood Donation (Largest) vs. Diagnostic Testing (Fastest-Growing) In the Blood Collection Market, the primary application segments include Blood Donation, Blood Transfusion, Diagnostic Testing, and Therapeutic Apheresis, with Blood Donation commanding the largest market share. Blood Donation is crucial in supporting healthcare systems and ensuring a steady supply of blood for various medical applications. Among these segments, Diagnostic Testing is emerging as the fastest-growing segment, driven by the increased need for rapid and accurate disease diagnosis. The growth trends indicate a heightened emphasis on the importance of blood donation amidst rising healthcare demands. Factors such as advancements in technology for blood collection and processing, increasing awareness about the significance of blood donations, and a growing number of diagnostic procedures are propelling the Diagnostic Testing segment forward. This robust growth trajectory is characterized by innovation in blood testing methods and a shift towards more efficient blood collection techniques, reflecting the evolving needs of the [healthcare industry](https://www.marketresearchfuture.com/reports/healthcare-industry-68323). Blood Donation (Dominant) vs. Therapeutic Apheresis (Emerging) Blood Donation serves as the foundational element for the Blood Collection Market, significantly influencing its dynamics. It plays a critical role in providing essential medical resources necessary for surgeries, treatments, and emergency care. Its dominant position is largely attributed to increased public awareness and regular campaigns encouraging voluntary donations. On the other hand, Therapeutic Apheresis is an emerging segment that is gaining traction due to its specialized applications in treating various medical conditions, such as autoimmune disorders and renal issues. Although it currently holds a smaller market share compared to Blood Donation, the rising prevalence of such conditions and advancements in apheresis technology are anticipated to propel this segment's growth, establishing its significance within the broader landscape of the Blood Collection Market. ### By Product Type: Blood Collection Tubes (Largest) vs. Blood Collection Devices (Fastest-Growing) The Blood Collection Market is characterized by a diverse range of product types, each contributing to the overall landscape. Blood Collection Tubes hold a significant share as the largest segment, catering to a variety of diagnostics and laboratory requirements. Needles and Syringes, along with Blood Bags, also play crucial roles, meeting the needs for various collection methods and storage solutions. Blood Collection Devices, while smaller in share, have gained prominence due to technological advancements and increased adoption in clinical settings. Blood Collection Tubes (Dominant) vs. Blood Collection Devices (Emerging) Blood Collection Tubes remain the dominant product type in the Blood Collection Market due to their versatility and ease of use in various clinical applications. They are designed to minimize contamination and are available in various configurations tailored to specific tests and applications. On the other hand, Blood Collection Devices are emerging rapidly, driven by innovations that enhance safety, efficiency, and patient comfort. These devices increasingly incorporate features such as needleless technology and integrated blood collection systems, which are appealing due to their ability to streamline the collection process and reduce the risk of needlestick injuries. ### By End User: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing) The blood collection market is characterized by diverse end-users, with hospitals commanding the largest share. Hospitals account for a significant portion of the market due to their critical role in routine and emergency blood transfusions. Diagnostic laboratories, while smaller in share, are witnessing rapid growth as they expand their testing capabilities and cater to a growing demand for precise diagnostics. The combined presence of hospitals and diagnostic laboratories shapes the competitive landscape, emphasizing the need for innovative blood collection solutions. In terms of growth trends, hospitals continue to invest in advanced blood collection technologies to improve operational efficiency and patient care. Meanwhile, diagnostic laboratories are emerging as the fastest-growing segment driven by advancements in [laboratory automation](https://www.marketresearchfuture.com/reports/laboratory-automation-market-11830) and the rising prevalence of chronic diseases necessitating regular blood tests. The evolving healthcare landscape, including diagnostic needs and patient care prioritization, influences the dynamics of this segment. Hospitals (Dominant) vs. Blood Banks (Emerging) Hospitals represent the dominant force in the blood collection market, leveraging their vast infrastructure to implement advanced blood collection and transfusion processes. They not only serve a critical function in patient care but also dictate the quality standards and practices for blood collection. As a trusted provider of critical medical services, hospitals are increasingly adopting technologies that enable safer and more efficient blood collection, making them the leaders in the sector. Conversely, blood banks are emerging as an important segment, responding to the growing demand for stored blood products and enhanced inventory management solutions. As the need for blood transfusions rises, blood banks are innovating by integrating modern collection techniques and inventory systems, positioning themselves as vital players in addressing nationwide blood shortages. ## Regional Market Share Analysis ### North America : Market Leader in Blood Collection North America continues to lead the blood collection market, holding a significant share of 2.5 billion in 2024. The region's growth is driven by increasing healthcare expenditures, advancements in medical technology, and a rising demand for blood transfusions. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficiency in blood collection processes. The competitive landscape is robust, with key players such as Thermo Fisher Scientific, BD, and Abbott Laboratories dominating the market. The U.S. remains the largest contributor, supported by a well-established healthcare infrastructure and ongoing innovations in blood collection devices. This competitive environment fosters continuous improvement and adaptation to emerging healthcare needs. ### Europe : Emerging Market with Growth Potential Europe's blood collection market is valued at 1.5 billion, reflecting a growing demand for efficient blood collection methods. Factors such as an aging population, increased prevalence of chronic diseases, and supportive regulatory frameworks are driving this growth. The European Medicines Agency (EMA) emphasizes the importance of safe blood collection practices, which further enhances market dynamics. Leading countries like Germany, France, and the UK are at the forefront of this market, with significant investments in healthcare infrastructure. Major players, including Roche Diagnostics and Siemens Healthineers, are actively innovating to meet the rising demand. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing product offerings and market reach. ### Asia-Pacific : Rapidly Growing Blood Collection Sector The Asia-Pacific blood collection market, valued at 1.0 billion, is experiencing rapid growth due to increasing healthcare investments and a rising population. The demand for blood collection is driven by a surge in diagnostic testing and the need for safe blood transfusions. Government initiatives aimed at improving healthcare access and quality are also significant growth catalysts in this region. Countries like Japan, China, and India are leading the market, with a growing presence of key players such as Sekisui Medical. The competitive landscape is evolving, with local manufacturers emerging alongside established global companies. This dynamic environment fosters innovation and enhances the availability of advanced blood collection solutions. ### Middle East and Africa : Emerging Market with Challenges The Middle East and Africa blood collection market is valued at 0.13 billion, reflecting a nascent but growing sector. Key growth drivers include increasing healthcare investments and rising awareness of blood donation. However, challenges such as regulatory hurdles and limited healthcare infrastructure can impede market growth. Governments are focusing on improving healthcare systems, which is expected to enhance blood collection practices in the region. Countries like South Africa and the UAE are leading the market, with efforts to improve blood donation rates and collection methods. The presence of key players is gradually increasing, with local and international companies working to address the unique challenges of this region. This evolving landscape presents opportunities for growth and innovation. ## Competitive Benchmarking The Blood Collection Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing demand for blood products, and a growing emphasis on patient safety. Key players such as Thermo Fisher Scientific (US), BD (US), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Thermo Fisher Scientific (US) focuses on innovation through the development of advanced blood collection systems, while BD (US) emphasizes strategic partnerships to expand its product offerings. Abbott Laboratories (US) is leveraging its strong research capabilities to introduce novel blood collection devices, thereby enhancing its competitive positioning.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Roche Diagnostics (CH) and Siemens Healthineers (DE) suggests a trend towards consolidation, as these firms seek to enhance operational efficiencies and broaden their geographic reach. In November Roche Diagnostics (CH) announced the launch of a new line of automated blood collection systems designed to improve efficiency and reduce the risk of contamination. This strategic move is likely to bolster Roche's position in the market by addressing the growing demand for safer and more efficient blood collection methods. The introduction of automation aligns with broader industry trends towards digitalization and operational efficiency. In October Siemens Healthineers (DE) entered into a partnership with a leading healthcare technology firm to integrate AI capabilities into its blood collection processes. This collaboration aims to enhance data analytics and improve patient outcomes. By leveraging AI, Siemens Healthineers (DE) is positioning itself as a leader in the integration of technology within the blood collection sector, potentially setting new standards for operational excellence. In September BD (US) expanded its manufacturing capabilities in Asia to meet the rising demand for blood collection products in emerging markets. This expansion not only enhances BD's supply chain resilience but also allows the company to better serve local healthcare providers. Such strategic moves indicate a shift towards regional manufacturing, which may become increasingly important in a post-pandemic world. As of December the Blood Collection Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming pivotal in shaping the competitive landscape, as companies collaborate to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology integration, and supply chain reliability, reflecting the industry's response to changing market demands. ## Recent News & Developments - **Q2 2024: BD Launches UltraTouch™ Push Button Blood Collection Market Set to Enhance Patient Comfort and Safety** Becton, Dickinson and Company (BD) announced the launch of the UltraTouch™ Push Button Blood Collection Market Set, designed to improve patient comfort and healthcare worker safety during blood draws. - **Q2 2024: Greiner Bio-One Launches VACUETTE® EVOPROTECT Safety Blood Collection Market Set in the U.S.** Greiner Bio-One announced the U.S. launch of its VACUETTE® EVOPROTECT Safety Blood Collection Market Set, a device aimed at reducing needlestick injuries and improving blood collection safety. - **Q2 2024: Seventh Sense Biosystems Announces FDA Clearance for TAP II Blood Collection Market Device** Seventh Sense Biosystems received FDA clearance for its TAP II device, a push-button blood collection device designed for virtually painless capillary blood collection. - **Q2 2024: Babson Diagnostics Receives FDA 510(k) Clearance for BetterWay Blood Collection Market Device** Babson Diagnostics announced it has received FDA 510(k) clearance for its BetterWay blood collection device, which enables small-volume blood collection for diagnostic testing. - **Q3 2024: Tasso Announces Partnership with Labcorp to Expand At-Home Blood Collection Market Services** Tasso, Inc. announced a partnership with Labcorp to provide at-home blood collection devices for diagnostic testing, expanding access to remote healthcare services. - **Q3 2024: Owen Mumford Opens New Automated Manufacturing Facility for Blood Collection Market Devices in Oxfordshire** Owen Mumford announced the opening of a new automated manufacturing facility in Oxfordshire, UK, dedicated to the production of blood collection devices. - **Q3 2024: BD Appoints New President of Integrated Diagnostic Solutions Segment** Becton, Dickinson and Company (BD) announced the appointment of a new president for its Integrated Diagnostic Solutions segment, which includes blood collection products. - **Q4 2024: Tasso Raises $40 Million in Series C Funding to Accelerate Blood Collection Market Device Commercialization** Tasso, Inc. raised $40 million in Series C funding to support the commercialization and scaling of its at-home blood collection devices. - **Q4 2024: Sarstedt Receives CE Mark for S-Monovette® Blood Collection Market System** Sarstedt announced it has received CE Mark approval for its S-Monovette® blood collection system, allowing for expanded distribution in the European market. - **Q1 2025: Babson Diagnostics Announces Strategic Partnership with Walgreens for Blood Collection Market Services** Babson Diagnostics announced a strategic partnership with Walgreens to offer blood collection services at select pharmacy locations. - **Q1 2025: Greiner Bio-One Expands Blood Collection Market Tube Production Capacity in North Carolina** Greiner Bio-One announced the expansion of its blood collection tube production facility in Monroe, North Carolina, to meet growing demand. - **Q2 2025: BD Acquires Velano Vascular to Expand Blood Collection Market Technology Portfolio** Becton, Dickinson and Company (BD) announced the acquisition of Velano Vascular, a company specializing in needle-free blood collection technology, to enhance its product offerings. ## Report Scope | MARKET SIZE 2024 | 5.13(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 5.44(USD Billion) | | MARKET SIZE 2035 | 9.67(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.93% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Thermo Fisher Scientific (US), BD (US), Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Greiner Bio-One (DE), Cardinal Health (US), Sekisui Medical (JP), F. Hoffmann-La Roche (CH) | | Segments Covered | Application, Product Type, End User | | Key Market Opportunities | Integration of advanced automation and digital solutions in the Blood Collection Market enhances efficiency and accuracy. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and efficiency in the blood collection market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Blood Collection Market by 2035?** A: The Blood Collection Market is projected to reach a valuation of 9.67 USD Billion by 2035. **Q: What was the market valuation of the Blood Collection Market in 2024?** A: In 2024, the Blood Collection Market was valued at 5.13 USD Billion. **Q: What is the expected CAGR for the Blood Collection Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Blood Collection Market during the forecast period 2025 - 2035 is 5.93%. **Q: Which application segment is anticipated to grow the most in the Blood Collection Market?** A: The Blood Transfusion segment, valued at 2.87 USD Billion, is anticipated to grow significantly in the Blood Collection Market. **Q: What are the key product types in the Blood Collection Market?** A: Key product types include Blood Collection Tubes, Needles and Syringes, Blood Bags, and Blood Collection Devices. **Q: Which end user segment is projected to have the highest valuation by 2035?** A: By 2035, the Hospitals segment is projected to reach a valuation of 2.85 USD Billion. **Q: Who are the leading companies in the Blood Collection Market?** A: Leading companies in the Blood Collection Market include Thermo Fisher Scientific, Becton Dickinson and Company, and F. Hoffmann-La Roche Ltd. **Q: What was the valuation of Blood Collection Tubes in 2024?** A: In 2024, the valuation of Blood Collection Tubes was 1.54 USD Billion. **Q: How does the Blood Collection Market's growth compare across different end users?** A: The Blood Collection Market shows varied growth, with Diagnostic Laboratories projected to grow from 1.03 to 1.92 USD Billion by 2035. **Q: What is the projected growth for the Therapeutic Apheresis segment by 2035?** A: The Therapeutic Apheresis segment is projected to grow from 1.28 USD Billion to 2.50 USD Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/blood-collection-market-7013*